Prescriber's Letter | Unbiased Medication Updates & CME

May 2025 Issue

Understand the Role of OTC Continuous Glucose Monitoring

You’ll get questions about the new OTC continuous glucose monitoring (CGM) devices...

Resources

FAQ: Continuous Glucose Monitoring

Evaluate Appropriate Use of Opioid and Benzodiazepine Combos

You’ll see an even bigger push to avoid opioid and benzodiazepine combos in older patients...

Help Keep the Facts Straight About Expired Meds

Misinformation about expired meds never seems to go out of date...

Get to Know Rx and OTC Fluoride Products

Questions will come up about fluoride supplementation...

GO TO FULL ISSUE

CE & Training

NEW REQUIRED COURSE: Substance Use Disorders and Pain Management: MATE Act Training

CE-IN-THE-LETTER: Prescriber Insights May 2025

LIVE CE: Antidepressants: Answering Your Big Questions

PODCAST CE: Medication Talk - Medications for Opioid Use Disorder

GO TO CE & TRAINING ORGANIZER

Featured Clinical Resources

GO TO ALL CLINICAL RESOURCES >

What is Prescriber Insights?

Prescriber Insights is the fastest, most trustworthy way for physicians, APRNs, and PAs to find out how drug therapy changes should fit into your practice. It's unbiased, evidence-based, and 100% free from financial support of the pharma industry. Learn more >

Group Purchases & Pricing

Prescriber Insights is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information

Welcome to Your Prescriber Insights

We value you and hope you take advantage of all the features of your subscription. For example, ask medication therapy questions and provide answers alongside your colleagues in the Forum.